Integrated BioPharma, Inc. (INBP)

OTCMKTS · Delayed Price · Currency is USD
0.290
+0.001 (0.35%)
Nov 7, 2024, 3:00 PM EST
8.61%
Market Cap 8.82M
Revenue (ttm) 50.32M
Net Income (ttm) 112.00K
Shares Out 30.10M
EPS (ttm) 0.00
PE Ratio 80.79
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,690
Open 0.289
Previous Close 0.289
Day's Range 0.289 - 0.290
52-Week Range 0.160 - 0.350
Beta 0.67
Analysts n/a
Price Target n/a
Earnings Date Nov 8, 2024

About Integrated BioPharma

Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through two segments, Contract Manufacturing and Other Nutraceutical Businesses. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes he... [Read more]

Industry Packaged Foods
Founded 1980
Employees 147
Stock Exchange OTCMKTS
Ticker Symbol INBP
Full Company Profile

Financial Performance

Financial Statements

News

Integrated BioPharma reports Q4 results

6 weeks ago - Seeking Alpha

Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024

HILLSIDE, NJ / ACCESSWIRE / September 20, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2024. Re...

6 weeks ago - Accesswire

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024

HILLSIDE, NJ / ACCESSWIRE / May 10, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2024. Revenue for each of the...

6 months ago - Accesswire

Integrated BioPharma Reports Results for its Quarter Ended December 31, 2023

HILLSIDE, NJ / ACCESSWIRE / February 12, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2023. Revenue for the...

9 months ago - Accesswire

Integrated BioPharma Reports Results for its Quarter Ended September 30, 2023

HILLSIDE, NJ / ACCESSWIRE / November 9, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2023. Revenue for the...

1 year ago - Accesswire

Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023

HILLSIDE, NJ / ACCESSWIRE / September 15, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2023. Re...

1 year ago - Accesswire

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2023

HILLSIDE, NJ / ACCESSWIRE / May 11, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2023. Revenue for the quarter...

1 year ago - Accesswire

Integrated BioPharma Announces the Sudden Death of Its Executive Chairman and President

HILLSIDE, NJ / ACCESSWIRE / March 21, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announced that Edward G. Kay, the Company's Founder, Executive Chairman and President pas...

1 year ago - Accesswire

Integrated BioPharma Reports Results for its Quarter Ended December 31, 2022

HILLSIDE, NJ / ACCESSWIRE / February 10, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2022. Revenue for th...

1 year ago - Accesswire

Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2022

HILLSIDE, NJ / ACCESSWIRE / November 10, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2022. Revenue for th...

2 years ago - Accesswire

Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2022

HILLSIDE, NJ / ACCESSWIRE / September 13, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2022. Re...

2 years ago - Accesswire

Integrated BioPharma Announces Change in Directors

HILLSIDE, NJ / ACCESSWIRE / June 21, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announced today Mr. Carl DeSantis has resigned as a Class I Director from the Company's Bo...

2 years ago - Accesswire

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2022

HILLSIDE, NJ / ACCESSWIRE / May 12, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the fiscal quarter ended March 31, 2022. Revenue for the ...

2 years ago - Accesswire

Integrated BioPharma Reports Results for its Quarter Ended December 31, 2021

HILLSIDE, NJ / ACCESSWIRE / February 10, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2021. Revenue for the...

2 years ago - Accesswire

Integrated BioPharma Reports Results for its Quarter Ended September 30, 2021

HILLSIDE, NJ / ACCESSWIRE / November 10, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2021. Revenue for th...

3 years ago - Accesswire

Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2021

HILLSIDE, NJ / ACCESSWIRE / September 2, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2021. Rev...

3 years ago - Accesswire

OTC Markets Group Welcomes Integrated BioPharma, Inc. to OTCQX

NEW YORK, Jan. 22, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced Integrated BioPharma, Inc. (OTCQX: IN...

4 years ago - PRNewsWire

Integrated BioPharma: Strong Growth For Less Than A 5 P/E

The company's quarterly results saw revenue increase 33% and earnings increase 233% to $0.04 per share. With a current share price of about $0.60, the stock is trading for under 4x trailing earnings.

4 years ago - Seeking Alpha